Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A humanoid robot is being used at NDORMS in an attempt to grow tendon tissue for repairing shoulder injuries.

The humanoid robotic bioreactor at NDORMS © David Fisher

For more than 20 years, it has been possible to grow and stretch tissue cells outside of the human body using dynamic bioreactors; systems that control the conditions necessary for maintaining and stimulating living cells and tissues, while involving external mechanical stresses. However, it has still not been possible to produce tendon tissues of high enough quality to work successfully in human grafts.

An important limitation is in the method of mechanically stimulating the cells as Pierre-Alexis Mouthuy, lead author of the study explained. "We're far away from fully functional tendon tissue grafts, and this is partially because we're not providing the complexity of mechanical stresses that cells would experience in a human shoulder," he said. "Existing evidence suggests that delivering advanced physiologically-relevant mechanical cues, or realistic movement of the shoulder up, down, back and forward, with the cells being pushed, pulled, compressed and stretched, is important to mature the tissue properly."

Most current bioreactor systems are only able to deliver unidirectional stretching to the cells, so Pierre and the team from NDORMS looked to real-size musculoskeletal (MSK) humanoid robots as a possible solution to provide physiological stresses, i.e. multidirectional ones. MSK humanoid robots aim to replicate the human musculoskeletal system by mimicking the structure and mechanics of muscles, tendons and bones.

The flexible bioreactor chamber is subjected to repeated abduction-adduction exercises.The flexible bioreactor chamber is subjected to repeated abduction-adduction exercises.

Their paper, published in Communications Engineering, explains how they firstly designed a flexible bioreactor chamber. Inside the chamber, cells were grown on stretchy synthetic scaffolds while being perfused with culture medium (providing them with oxygen and nutrients). On a daily basis, the chambers were positioned on the robotic arm and were subjected to repeated abduction-adduction exercises to replicate some of the forces and movements that they would undergo in a real tendon.

Pierre and his team hope that, in the future, lab grown tendon grafts can be used to improve repair outcomes in patients. "Now that we've demonstrated the feasibility of a humanoid bioreactor approach, we can explore the possibilities of this new platform and see if providing these more physiologically relevant mechanical stresses can really help to improve the quality of engineered tendon grafts."

See the robotic bioreactor in action in this Nature video.

Similar stories

Emergency to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.